Cargando…
Enzyme-responsive mesoporous silica nanoparticles for tumor cells and mitochondria multistage-targeted drug delivery
Background: Drug delivery systems (DDS) capable of targeting both cell and organelle levels are highly desirable for effective cancer therapy. In this study, we developed a novel enzyme-responsive, multistage-targeted anticancer DDS based on mesoporous silica nanoparticles (MSNs), which possessed bo...
Autores principales: | Naz, Safia, Wang, Mingyu, Han, Yuning, Hu, Bin, Teng, Liping, Zhou, Juan, Zhang, Huijie, Chen, Jinghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497824/ https://www.ncbi.nlm.nih.gov/pubmed/31114189 http://dx.doi.org/10.2147/IJN.S202210 |
Ejemplares similares
-
Mesoporous silica nanoparticles for drug and gene delivery
por: Zhou, Yixian, et al.
Publicado: (2018) -
Silica-based mesoporous nanoparticles for controlled drug delivery
por: Kwon, Sooyeon, et al.
Publicado: (2013) -
Mesoporous Silica Nanoparticles for Drug Delivery: Current Insights
por: Vallet-Regí, María, et al.
Publicado: (2017) -
Mesoporous Silica Nanoparticles as Drug Delivery Vehicles in Cancer
por: Watermann, Anna, et al.
Publicado: (2017) -
Mesoporous Silica Nanoparticles for Protein Protection and Delivery
por: Xu, Chun, et al.
Publicado: (2019)